Thursday, February 2, 2023
THE SENIOR HEALTH LETTER
No Result
View All Result
  • Home
  • Home Care
  • Elder Care
  • Wellness
  • Dementia
  • Caregivers
  • Alzheimer’s
  • Assisted living
  • Mindfulness
  • Seniors advocate
The Senior Health Letter
No Result
View All Result
Home Alzheimer's

Real reason for hope in Alzheimer’s research

Delmar by Delmar
March 14, 2021
in Alzheimer's
0
Real reason for hope in Alzheimer’s research
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter


With apologies to John Steinbeck for borrowing his phrases, right this moment I need to speak of mice and males — and girls.

As a result of my subject is Alzheimer’s analysis, which individuals with gentle cognitive impairment are usually extremely interested by. I perceive why. It offers folks with MCI hope.

Hope is an efficient factor. I would like you to have hope.

And hope is an efficient factor. I would like you to have hope. However I additionally need you to know easy methods to make sense of Alzheimer’s analysis, and the place to position that hope. So let’s speak about that right this moment.

Hello, I’m Tony Dearing, of GoCogno.com, the web site for folks with gentle cognitive impairment.

There was a headline not too long ago that prompted a variety of pleasure. It concerned a study suggesting that melatonin, a complement already offered as a sleep help, could enhance reminiscence. A quantity readers ship the hyperlink to me, asking, “Tony, have you ever seen this? What do you assume?”

I observe Alzheimer’s analysis very intently, and what I take into consideration any specific drug or examine depends upon what stage it’s in.

When scientists are taking a look at one thing like this, step one is to check it on mice, which is what they did right here. If it really works on mice, that’s encouraging.

What I take into consideration any specific drug or examine depends upon what stage it’s in.

The subsequent step is to check it on a small variety of people, in a Part II trial, to see if they’ll take it safely and see if it helps them. If it really works on people, that’s when the outcomes turn out to be promising.

Sadly, in mind well being analysis, lots of the medicine or dietary supplements that work on mice find yourself not engaged on people. Greater than 500 substances have been proven to “treatment” Alzheimer’s in mice, however once they have been tried on people, they didn’t work.

Now, the outcomes of this new examine are spectacular, and nearly actually will lead to a Part II trial. If that examine is profitable, then we’re on to one thing. We simply have to attend and see.

However the factor I at all times need to remind folks is though a solution on this one continues to be years away, there are numerous promising medicine for dementia and MCI in Part 3 medical trials proper now. They labored on mice they usually labored on a small variety of folks, and now they’re in a lot bigger research.

For instance, listed here are two wonderful prospects that I’ve written about.

Ragasiline as a promising Alzheimer’s treatment

Drug derived from seaweed approved to treat Alzheimer’s in China

Both of them has a extremely good probability of being that breakthrough we’ve been ready for.

Perhaps you might be a part of the answer, by volunteering for a medical trial.

So sure, there’s motive for hope, and I would like you to carry onto that hope. Perhaps you are able to do greater than hope. Perhaps you might be a part of the answer, by volunteering for a medical trial, for those who’re eligible for one close to you. It’s one thing to think about, and for those who’re interested by exploring that, right here’s a hyperlink for extra info. You should utilize the locator software from the Nationwide Institutes of Well being to search out medical trials for MCI and dementia here.

Thanks for becoming a member of me right this moment. I’ll see you once more subsequent week. Till then, as at all times, be form to your thoughts.



Source link

Tags: AlzheimershopeRealreasonresearch
Advertisement Banner
Previous Post

B.C. top doctor apologizes for seniors’ COVID-19 vaccine delay

Next Post

Trio is trouble in assisted living: Risky neuro drug combos too common, dementia expert says – Clinical Daily News

Delmar

Delmar

Next Post
Trio is trouble in assisted living: Risky neuro drug combos too common, dementia expert says – Clinical Daily News

Trio is trouble in assisted living: Risky neuro drug combos too common, dementia expert says - Clinical Daily News

Discussion about this post

Recommended

Elder Care Services & Assistive Devices Market Size, Future Trends, Segmentation, Gross Margin, Opportunity Assessment and Potential of the Industry by 2027

Elder Care Services & Assistive Devices Market Size, Future Trends, Segmentation, Gross Margin, Opportunity Assessment and Potential of the Industry by 2027

2 years ago
home care Archives – Suburban Chicagoland

home care Archives – Suburban Chicagoland

2 years ago

Don't Miss

(2021-2026) Nursing Home Beds Market Size, Demand Status | Global Industry Segment Analysis, Growing Status of Key Players

Advice You Need To Know About Personal Development

May 12, 2021
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

Advocate Aurora Enterprises acquires national leader in home care and wellness offerings Senior Helpers

April 1, 2021
‘I’m in jail’: BPS mothers and caregivers voice concerns with district reopening plans

‘I’m in jail’: BPS mothers and caregivers voice concerns with district reopening plans

April 1, 2021
As Loved Ones Reunite After A Year, Dementia Experts Offer These Tips

As Loved Ones Reunite After A Year, Dementia Experts Offer These Tips

April 1, 2021

Categories

  • Alzheimer's
  • Assisted living
  • Caregivers
  • Dementia
  • Elder Care
  • Home Care
  • Mindfulness
  • Seniors advocate
  • Uncategorized
  • Wellness

Follow us

Recent News

(2021-2026) Nursing Home Beds Market Size, Demand Status | Global Industry Segment Analysis, Growing Status of Key Players

Advice You Need To Know About Personal Development

May 12, 2021
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

Advocate Aurora Enterprises acquires national leader in home care and wellness offerings Senior Helpers

April 1, 2021
March 2021
S M T W T F S
 123456
78910111213
14151617181920
21222324252627
28293031  
    Apr »
  • About Us
  • Contact Us
  • Privacy & Policy

© 2021 The Senior health Letter

No Result
View All Result
  • Home
  • Home Care
  • Elder Care
  • Wellness
  • Dementia
  • Caregivers
  • Alzheimer’s
  • Assisted living
  • Mindfulness
  • Seniors advocate

© 2021 The Senior health Letter